Iran's Razi-COV Pars vaccine entered third phase of clinical trial

Tehran (IP) - The Ministry of Health of Iran has approved the start of the third phase of Iran's COVID-19 vaccine clinical trial named 'Razi-COV Pars'.

Iran PressIran news: The COVID-19 vaccine of Razi Vaccine and Serum Research Institute entered the third phase of a clinical trial with the permission of the Research Ethics Committee of the Ministry of Health and Medical Education of Iran.

With this approval, the third phase of the clinical trial of this vaccine will begin immediately.


Read more:

Iran pays COVAX to get vaccine soon; WHO rep. says

Iran's FM expresses readiness to accelerate supply of COVID-19 vaccines